Anyone who is truly knowledgeable will have signed a non disclosure agreement and would face trouble if they told you what they know.
What we do know from what is publicly available is that there should be an update on the phase 2 cervical cancer data this quarter, and that now seems to be happening Monday. That data should be at least as good as the interim results that we have already seen. Six complete responses and five partial responses out of the 110 who had a death sentence. And that is with a therapy that is amazingly safe.
This quarter we are also expecting the report on the Phase 2 mid-dose CIN study. There is no reason to also expect that on Monday, but it is coming.
In Quarter 2 we are looking forward to a further update from India but more importantly (in my opinion) the Phase 1 study for prostate cancer should get under way.
A partnership agreement at least for the HPV construct could be announced at any time but we don't have any schedule for that.
Go to the Advaxis web site and watch Tom Moore's previous presentations.